Clinical Trial Update: Paclitaxel for the Treatment of Distal Radial Artery Arteriovenous Access Fistula Stenosis (PaciFIST-2) [Phase 2]

View source ↗

Summary

Phase 2 trial PaciFIST-2 evaluating paclitaxel for distal radial artery arteriovenous fistula stenosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula Stenosis

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Englewood Hospital and Medical Center | Conditions: Arteriovenous Access Fistula Stenosis | Phase 2 | Status: WITHDRAWN